GlassScriptPrepare for your visit
Zaineb Daud
Neurology (Psychiatry & Neurology) · Philadelphia, MS · NPI 1568468908
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$8,191.38
in general payments reported to CMS, 2019-2025 · $1,519 in 2025
The $1,519 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Acadia Pharmaceuticals INC $1,150.20
- Lilly USA, LLC $938.18
- Teva Pharmaceuticals USA, INC. $732.46
- Pfizer INC. $570.01
- Sk Life Science, INC. $539.89
- Novartis Pharmaceuticals Corporation $411.81
Drugs and devices associated with these payments
Nuplazid Nurtec Odt Zavzpret Kesimpta Acthar Kisunla Aptiom Purified Cortrophin Gel Emgality Vyepti Paxlovid Ubrelvy
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Zaineb Daud listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1204772/zaineb-daud